Skip to main content
    K

    Kewaunee Scientific Corporation (KEQU)

    Official site

    CONSUMER CYCLICAL • FURNISHINGS, FIXTURES & APPLIANCES • NASDAQ

    $34.01
    -1.04 (-2.97%)

    Market Cap: $101.49M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Kewaunee Scientific Corporation (KEQU) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Kewaunee Scientific (KEQU) has a market cap of $101.49M and an enterprise value of $112.61M. Its return on invested capital of 12.38% compares with a 3.10% median across 9 similar companies.

    Total Valuation

    Enterprise value is 10.95% above the market cap, as debt exceeds cash.

    Market Cap$101.49M
    Enterprise Value$112.61M
    Latest price (Nov 17, 2026)$34.01

    Key Dates

    The next earnings report is expected on Dec 16, 2026, covering the quarter ending Oct 31, 2026.

    Next Earnings DateDec 16, 2026 (expected)
    Last Earnings DateSep 9, 2026
    Fiscal Year EndApril

    Share Statistics

    The share count fell 3.84% in the quarter ended Jul 31, 2026 and grew 0.54% a year over 2 years.

    Shares Outstanding2.88M
    Shares Change (YoY)+1.02%
    Shares Change (QoQ)-3.84%
    Share Count Growth (2Y CAGR)+0.54%

    Valuation Ratios

    Sales and book value multiples are 0.4x and 1.3x. Its year-end P/E ranged from 7.5x to 17.3x from 2016 to 2025.

    P/E Ratio11.9x
    P/S Ratio0.4x
    P/B Ratio1.3x
    P/TBV Ratio2.1x
    P/FCF Ratio9.0x
    P/OCF Ratio6.8x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 4.8x EBITDA and 10.0x free cash flow.

    EV / Earnings12.3x
    EV / Sales0.4x
    EV / EBITDA4.8x
    EV / EBIT7.1x
    EV / FCF10.0x

    Price Statistics

    The stock is down 15.86% over 52 weeks and trades 0.35% above its 50-day average.

    Beta (1Y)0.47
    52-Week Change-15.86%
    1-Month Change+5.95%
    3-Month Change-5.55%
    6-Month Change-11.75%
    5-Year Change+161.25%
    10-Year Change+49.55%
    Total Return (1Y)-15.86%
    Total Return (3Y CAGR)+22.58%
    Total Return (5Y CAGR)+21.79%
    Return vs SPY (1Y)-25.37%
    Max Drawdown (1Y)-25.52%
    Max Drawdown (3Y)-55.36%
    Sharpe Ratio (1Y)-0.42
    Correlation with SPY (1Y)0.18
    50-Day Average$33.89
    200-Day Average$36.52
    52-Week Range$32.00 to $43.36
    RSI (14 Days)49.9
    Average Volume (20 Days)5.23K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.20x current liabilities, and total debt is 0.26x shareholder equity.

    Current Ratio2.20x
    Quick Ratio1.57x
    Debt / Equity0.26x
    Debt / EBITDA0.85x
    Debt / FCF1.78x
    Interest Coverage4.61x

    Returns and Efficiency

    Return on invested capital is 12.38% over the last 12 months, against a 5-year average of 17.91%.

    Return on Equity (ROE)12.20%
    Return on Assets (ROA)5.20%
    Return on Invested Capital (ROIC)12.38%
    Return on Capital Employed (ROCE)12.29%
    ROE (5Y Average)10.72%
    ROA (5Y Average)4.41%
    ROIC (5Y Average)17.91%
    Asset Turnover1.50x
    Inventory Turnover6.57x
    Receivables Turnover4.74x
    Cash Conversion Cycle92 days

    Taxes

    Income tax took 26.06% of pretax income over the last 12 months.

    Income Tax (TTM)$3.22M
    Effective Tax Rate26.06%

    Scores

    KEQU has an Altman Z-Score of 3.42, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score3.42
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $277.21M over the last 12 months is up 5.33% from the 12 months before.

    Revenue$277.21M
    Revenue Growth (YoY)+5.33%
    Gross Profit$79.15M
    Operating Income$15.06M
    Pretax Income$12.37M
    Net Income$9.15M
    EBITDA$22.66M
    EBIT$15.80M
    Reported EPS (TTM)$2.86

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 42.66% of the $175.80M in total assets.

    Cash and Equivalents$8.25M
    Total Debt$19.36M
    Net Debt$11.12M
    Net Debt Per Share$3.86
    Working Capital$56.72M
    Shareholder Equity$75.00M
    Book Value Per Share$26.04
    Tangible Book Value$46.61M
    Tangible Book Per Share$16.18
    Total Assets$175.80M
    Total Liabilities$98.58M

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    After $3.94M of capital spending, operating cash flow left $10.88M of free cash flow.

    Operating Cash Flow$14.82M
    Capital Expenditures$3.94M
    Free Cash Flow$10.88M
    FCF Per Share$3.76
    Depreciation and Amortization$6.85M

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is 5.43%, against a 5-year average of 4.64%.

    Gross Margin28.55%
    Operating Margin5.43%
    Pretax Margin4.46%
    Net Margin3.30%
    EBITDA Margin8.17%
    EBIT Margin5.70%
    FCF Margin3.92%
    Gross Margin (5Y Average)22.65%
    Operating Margin (5Y Average)4.64%
    Net Margin (5Y Average)2.99%

    Growth

    Revenue grew 8.71% a year over 3 years, and EPS 141.55% a year.

    Revenue Growth (3Y CAGR)+8.71%
    Revenue Growth (5Y CAGR)+13.84%
    EPS Growth (3Y CAGR)+141.55%
    Operating Income Growth (3Y CAGR)+46.06%
    Book Value Per Share Growth (2Y CAGR)+16.36%
    Tangible Book Per Share Growth (2Y CAGR)-8.76%

    Revenue and profit by year

    Dividends and Yields

    KEQU does not pay a dividend. Its free cash flow yield is 11.11%.

    Earnings Yield8.40%
    FCF Yield11.11%
    Buyback Yield0.54%

    Peer Position

    Against 7 similar companies, KEQU has the 4th highest P/E.

    P/E Ratio11.9x vs 11.5x median
    P/S Ratio0.4x vs 0.5x median
    ROIC12.38% vs 3.10% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.33% vs +0.48% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About KEQU

    What is KEQU's market cap?

    Kewaunee Scientific has a market cap of $101.49M. Its enterprise value, which adds debt and subtracts cash, is $112.61M.

    What is KEQU's P/E ratio?

    Kewaunee Scientific has a trailing P/E ratio of 11.9x.

    How many shares of KEQU are outstanding?

    Kewaunee Scientific has 2.88M shares outstanding. The count is up 1.02% from a year earlier.

    Does KEQU pay a dividend?

    No. Kewaunee Scientific does not pay a dividend.

    How much debt does KEQU have?

    Kewaunee Scientific has $19.36M of total debt and $8.25M of cash and equivalents, a net debt position of $11.12M.